Poseida Therapeutics Inc
NASDAQ:PSTX

Watchlist Manager
Poseida Therapeutics Inc Logo
Poseida Therapeutics Inc
NASDAQ:PSTX
Watchlist
Price: 2.71 USD -0.37% Market Closed
Market Cap: 264.1m USD
Have any thoughts about
Poseida Therapeutics Inc?
Write Note

Wall Street
Price Targets

PSTX Price Targets Summary
Poseida Therapeutics Inc

Wall Street analysts forecast PSTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PSTX is 14.28 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.

Lowest
Price Target
10.1 USD
273% Upside
Average
Price Target
14.28 USD
427% Upside
Highest
Price Target
21 USD
675% Upside
Poseida Therapeutics Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
31% Upside
TNGX
Tango Therapeutics Inc
200% Upside
GNFT
Genfit SA
134% Upside
KMDA
Kamada Ltd
156% Upside
IDYA
IDEAYA Biosciences Inc
108% Upside
ADMA
ADMA Biologics Inc
13% Upside
OXB
Oxford BioMedica PLC
25% Upside
TNG
Transgene SA
283% Upside

Revenue
Forecast

Revenue Estimate
Poseida Therapeutics Inc

For the last 6 years the compound annual growth rate for Poseida Therapeutics Inc's revenue is 67%. The projected CAGR for the next 3 years is -30%.

67%
Past Growth
-30%
Estimated Growth
Estimates Accuracy
32%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Poseida Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Poseida Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PSTX's stock price target?
Price Target
14.28 USD

According to Wall Street analysts, the average 1-year price target for PSTX is 14.28 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.

What is Poseida Therapeutics Inc's Revenue forecast?
Projected CAGR
-30%

For the last 6 years the compound annual growth rate for Poseida Therapeutics Inc's revenue is 67%. The projected CAGR for the next 3 years is -30%.

Back to Top